全文获取类型
收费全文 | 566篇 |
免费 | 31篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 3篇 |
儿科学 | 39篇 |
妇产科学 | 6篇 |
基础医学 | 48篇 |
口腔科学 | 14篇 |
临床医学 | 42篇 |
内科学 | 103篇 |
皮肤病学 | 7篇 |
神经病学 | 33篇 |
特种医学 | 93篇 |
外科学 | 51篇 |
综合类 | 64篇 |
一般理论 | 1篇 |
预防医学 | 35篇 |
眼科学 | 12篇 |
药学 | 17篇 |
肿瘤学 | 33篇 |
出版年
2022年 | 5篇 |
2021年 | 6篇 |
2020年 | 6篇 |
2019年 | 4篇 |
2018年 | 11篇 |
2017年 | 10篇 |
2016年 | 7篇 |
2015年 | 17篇 |
2014年 | 8篇 |
2013年 | 10篇 |
2012年 | 20篇 |
2011年 | 26篇 |
2010年 | 27篇 |
2009年 | 18篇 |
2008年 | 25篇 |
2007年 | 21篇 |
2006年 | 23篇 |
2005年 | 28篇 |
2004年 | 17篇 |
2003年 | 7篇 |
2002年 | 15篇 |
2001年 | 13篇 |
2000年 | 9篇 |
1999年 | 14篇 |
1998年 | 30篇 |
1997年 | 24篇 |
1996年 | 22篇 |
1995年 | 18篇 |
1994年 | 12篇 |
1993年 | 12篇 |
1992年 | 6篇 |
1989年 | 16篇 |
1988年 | 12篇 |
1987年 | 20篇 |
1986年 | 13篇 |
1985年 | 7篇 |
1984年 | 6篇 |
1983年 | 8篇 |
1982年 | 7篇 |
1981年 | 6篇 |
1980年 | 6篇 |
1976年 | 4篇 |
1975年 | 9篇 |
1974年 | 3篇 |
1973年 | 1篇 |
1970年 | 1篇 |
1969年 | 2篇 |
1966年 | 1篇 |
1965年 | 1篇 |
1960年 | 1篇 |
排序方式: 共有601条查询结果,搜索用时 46 毫秒
141.
142.
Background: Off-pump Coronary Artery Bypass (OPCAB) has become the standard surgical treatment of Coronary Artery Disease in most centres in India. It is clear from the current evidence that, in certain patients, OPCAB offers advantages over conventional Coronary Artery Bypass Grafting (CABG). Experience of this procedure in the Armed Forces is highlighted. 相似文献
143.
144.
MK Song MJ Rosenthal AM Song K Uyemura H Yang ME Ament DT Yamaguchi EM Cornford 《British journal of pharmacology》2009,158(2):442-450
Background and purpose:
We have previously shown that treatment with zinc plus cyclo-(His-Pro) (CHP) significantly stimulated synthesis of the insulin degrading enzyme and lowered plasma insulin and blood glucose levels, alongside improving oral glucose tolerance in genetically type 2 diabetic Goto-Kakizaki (G-K) rats and in aged obese Sprague-Dawley (S-D) rats. Thus, we postulated that zinc plus CHP (ZC) treatment might also improve body weight control in these rats. We therefore determined the effects of ZC treatment on body weights in both genetically diabetic, mature G-K rats and non-diabetic, obese S-D rats.Experimental approach:
G-K rats aged 1.5–10 months and non-diabetic overweight or obese S-D rats aged 6–18 months were treated with 0–6 mg CHP plus 0–10 mg zinc·L−1 drinking water for 2–4 weeks, and changes in weight, serum leptin and adiponectin levels, food and water intakes were measured.Key results:
The optimal dose of CHP (in combination with zinc) to reduce weight and plasma leptin levels and to increase plasma adiponectin levels was close to 0.1 mg·kg−1·day−1, in either mature G-K rats and aged overweight or obese S-D rats. Food and water intake significantly decreased in ZC treated rats in both aged S-D rats and mature G-K rats, but not in young S-D and G-K rats.Conclusions and implications:
ZC treatment improved weight control and may be a possible treatment for overweight and obesity. 相似文献145.
MK 《Best Practice Onkologie》2012,7(1):14
„ Jede Blutung unbekannter Ursache kann eine erworbene H?mophilie sein“, erkl?rte Dr. Andreas Tiede, Hannover. 相似文献
146.
Payne ET Yasuda N Bourgeois JM Devries MC Rodriguez MC Yousuf J Tarnopolsky MA 《Muscle & nerve》2006,33(1):66-77
Corticosteroid therapy for Duchenne muscular dystrophy is effective but associated with long-term side effects. To determine the potential therapeutic benefit from four nutritional compounds (creatine monohydrate, conjugated linoleic acid, alpha-lipoic acid, and beta-hydroxy-beta-methylbutyrate) alone, in combination, and with corticosteroids (prednisolone), we evaluated the effects on several variables in exercising mdx mice. Outcome measures included grip strength, rotarod performance, serum creatine kinase levels, muscle metabolites, internalized myonuclei, and retroperitoneal fat pad weight. In isolation, each nutritional treatment showed some benefit, with the combination therapy showing the most consistent benefits. Prednisolone and the combination therapy together provided the most consistent evidence of efficacy; increased peak grip strength (P < 0.05), decreased grip strength fatigue (P < 0.05), decreased number of internalized myonuclei (P < 0.01), and smaller retroperitoneal fat pad stores (P < 0.001). This study provided evidence for therapeutic benefit from a four-compound combination therapy alone, and in conjunction with corticosteroids in the mdx model of DMD. 相似文献
147.
148.
BACKGROUND: The basal insulin analogues glargine and detemir have been subject to a series of trials comparing their clinical profiles to the conventional preparation, neutral protamine Hagedorn (NPH). Careful review of these trials provides opportunities to learn clinically useful lessons about these insulins. METHODS: MedLine-indexed trials comparing glargine or detemir to NPH were scrutinized for control, tolerability and dose data. Separate considerations were made for types 1 and 2 diabetes, and for basal-bolus and basal plus oral glucose-lowering drugs (OGLD) therapy. Attention was paid to dosing schedules and 24-h glycaemic profiles. RESULTS: Collectively, the trials demonstrated an improved balance between glycaemic control and tolerability for both analogues compared to NPH, regardless of regimen and diabetes type. Neither once-daily glargine nor detemir reliably provides 24-h basal insulin replacement in all patients with type 1 diabetes; a waning of effect frequently obliges twice-daily administration. When added to OGLDs in type 2 diabetes, goal-titrated once-daily basal insulin generally lowered HbA(1c) by approximately 1.5%, whereas twice-daily administration tended to increase insulin dose disproportionately to improvement in control. Hence, adding bolus insulin may be a preferable intensification method to dividing the basal dose. Varying injection time or dividing the basal insulin dose predictably affects the pattern of hypoglycaemia and bolus dose requirements. Morning administration tends to require higher dosing than evening administration. CONCLUSIONS: Scrutiny of trials involving glargine and detemir has increased our understanding of how best to dose basal insulins. An individualized approach is still necessary however, and several questions remain that require further research. 相似文献
149.